Latest Breaking News On - Spanish network of cell therapy tercel - Page 1 : comparemela.com

The Stem Cells for Huntington’s Disease (SC4HD) is a new international consortium created to promote  advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington’s Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the  J ournal of Huntington’s Disease. The main goals of SC4HD researchers are to work together with the HD community, develop criteria and guidance and address the main challenges to rapidly and safely bring potentially beneficial stem cell-based therapies to patients with this devastating disease.  According to Josep M. Canals, director of Creatio and member of the steering committee of SC4HD, “there is an exciting opportunity to apply stem cell-based therapies in Huntington’s disease (HD), a devastating neurodegenerative disease that mainly affects neurons in the brain nucleus known as striatum”. 

Comunidad autonoma de catalunaValidation centerUniversity of barcelonaPii sunyer biomedical research instituteBiomedical research networking center on neurodegenerative diseasesDepartment of biomedicineSpanish network of cell therapy tercelInstitute of neurosciencesHealth sciencesStem cell based therapyStem cellsBiomedical sciencesAdvanced therapiesAdvanced therapy medicinal productsStem cellBiomedical research networking center